We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

172 hedge funds and large institutions have $997M invested in Arcus Biosciences in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 59 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more call options, than puts

Call options by funds: $5.35M | Put options by funds: $3.19M

3% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 59

2% less capital invested

Capital invested by funds: $1.02B → $997M (-$25.2M)

7% less funds holding

Funds holding: 185 → 172 (-13)

13.37% less ownership

Funds ownership: 71.53% → 58.16% (-13%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

39% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 31

Holders
172
Holders Change
-13
Holders Change %
-7.03%
% of All Funds
2.48%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
61
Reduced
59
Closed
31
Calls
$5.35M
Puts
$3.19M
Net Calls
+$2.16M
Net Calls Change
-$5.09M

Top Buyers

1
WP
Woodline Partners
California
+$31.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.8M
3
State Street
State Street
Massachusetts
+$11.5M
4
LCM
Laurion Capital Management
New York
+$9.47M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.43M

Top Sellers

1
OCA
Octagon Capital Advisors
New York
-$35.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.85M
3
Morgan Stanley
Morgan Stanley
New York
-$9.13M
4
Ameriprise
Ameriprise
Minnesota
-$7.5M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$6.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$187M -$2.33M -134,829 -1%
State Street
2
State Street
Massachusetts
$92.6M +$11.5M +664,936 +16%
Vanguard Group
3
Vanguard Group
Pennsylvania
$90.5M +$1.91M +110,528 +2%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$90.2M +$873K +50,487 +1%
WP
5
Woodline Partners
California
$54.4M +$31.9M +1,846,375 +178%
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$36.2M +$19.8M +1,146,182 +149%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$30.6M +$463K +26,800 +2%
IFA
8
Invus Financial Advisors
New York
$30.4M – – –
BC
9
Boxer Capital
California
$30.2M – – –
Ameriprise
10
Ameriprise
Minnesota
$22.7M -$7.5M -433,784 -27%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$22.1M +$515K +29,799 +3%
AllianceBernstein
12
AllianceBernstein
Tennessee
$21.7M -$602K -34,816 -3%
SCM
13
Suvretta Capital Management
New York
$18.1M – – –
Morgan Stanley
14
Morgan Stanley
New York
$16.5M -$9.13M -527,908 -38%
DC
15
Decheng Capital
California
$16.4M – – –
BNP Paribas Asset Management
16
BNP Paribas Asset Management
France
$12.9M +$2.51M +145,298 +27%
LCM
17
Laurion Capital Management
New York
$10.3M +$9.47M +547,474 New
Northern Trust
18
Northern Trust
Illinois
$9.69M -$194K -11,191 -2%
Charles Schwab
19
Charles Schwab
California
$9.31M +$365K +21,094 +4%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$7.56M -$304K -17,585 -4%
PAM
21
Panagora Asset Management
Massachusetts
$7.37M +$2.79M +161,303 +70%
Macquarie Group
22
Macquarie Group
Australia
$7.16M – – –
UBS AM
23
UBS AM
Illinois
$7.14M -$356K -20,603 -5%
Citadel Advisors
24
Citadel Advisors
Florida
$6.7M +$1.37M +78,997 +29%
Rafferty Asset Management
25
Rafferty Asset Management
New York
$6.41M +$1.53M +88,263 +35%
1
2 3 4 5

RCUS Hedge Fund Activity: Q1 2024 in Review

172 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2024, worth a combined $997M — down 2.5% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of RCUS and 19 opened new positions — a net loss of 12 holders — while 59 trimmed existing stakes and 61 added.

The largest buyer was Woodline Partners, adding an estimated $31.9M. The largest seller was Octagon Capital Advisors, exiting entirely with an estimated $35.7M sold.

  • 172 institutional investors held Arcus Biosciences (RCUS) as of Q1 2024, down from 185 in Q4 2023.
  • Funds reported $997M of Arcus Biosciences stock for Q1 2024, down 2.5% quarter-over-quarter.
  • 19 funds opened new Arcus Biosciences positions in Q1 2024 and 31 closed out, a net change of -12 holders.
  • The largest Arcus Biosciences buyer in Q1 2024 was Woodline Partners, an estimated $31.9M added.
  • The largest Arcus Biosciences seller in Q1 2024 was Octagon Capital Advisors, an estimated $35.7M sold.

Based on aggregated 13F filings for Q1 2024.